FXR1 Antibody (SR2140)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-22299
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # SR2140
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthesized peptide derived from human FXR1 (Uniprot #: P51114)
Specificity
Detects endogenous levels of total FXR1
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FXR1 Antibody (SR2140)
Western Blot: FXR1 Antibody (SR2140) [NBP3-22299] -
Western Blot: FXR1 Antibody (SR2140) [NBP3-22299] - Western blot analysis using NBP3-22299 in MCF7 cell lysate.Applications for FXR1 Antibody (SR2140)
Application
Recommended Usage
Flow Cytometry
1:50
Immunocytochemistry/ Immunofluorescence
1:50-1:200
Immunohistochemistry
1:50-1:200
Western Blot
1:500-1:2000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.4, 150mM NaCl, 50% glycerol.
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FXR1
Alternate Names
fragile X mental retardation syndrome-related protein 1, fragile X mental retardation, autosomal homolog 1, FXR1P, hFXR1p
Gene Symbol
FXR1
Additional FXR1 Products
Product Documents for FXR1 Antibody (SR2140)
Product Specific Notices for FXR1 Antibody (SR2140)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...